TITAN BIOTECH LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2022 inter alia to consider and approve Audited Financial Results for quarter and Financial year ended 31st March 2022 and recommendation of dividend on equity shares.